# Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans

> **NCT05145309** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 45 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** KMgCit
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05145309
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-15
- **Primary completion:** 2031-12-01
- **Final completion:** 2032-12-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05145309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05145309, "Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05145309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*